Department of Surgical Sciences, University of Insubria-Varese, Multimedica Santa Maria Hospital, Castellanza, Varese, Italy.
Ann Surg. 2012 Apr;255(4):650-7. doi: 10.1097/SLA.0b013e31824b32bf.
Test the hypothesis that fibrin sealant mesh fixation can reduce the incidence of postoperative pain/numbness/groin discomfort by up to 50% compared with sutures for repair of inguinal hernias using the Lichtenstein technique.
Inguinal hernia repair is the most common procedure in general surgery, thus improvements in surgical techniques, which reduce the burden of undesirable postoperative outcomes, are of clinical importance.
A randomized, controlled, patient- and evaluator-blinded study (Tissucol/Tisseel for MEsh fixation in LIchtenstein hernia repair [TIMELI]; trial NCT00306839) was conducted among patients eligible for Lichtenstein repair of uncomplicated unilateral primary inguinal small-medium sized hernia. Patients were subject to mesh fixation with either fibrin sealant or sutures. Main outcome measures were visual analogue scale (VAS) assessments for "pain," "numbness," and "groin discomfort" on a scale of 0 = best and 100 = worst outcome. The primary endpoint was a composite that evaluated the prevalence of chronic disabling complications (VAS score >30 for pain/numbness/groin discomfort) at 12 months after surgery.
In total, 319 patients were randomized between January 2006 and April 2007 (159 fibrin sealant, 160 sutures). At 12 months, the prevalence of 1 or more disabling complication was significantly lower in the fibrin sealant group than in the sutures group (8.1% vs 14.8%; P = 0.0344). Less pain was reported in the fibrin sealant group than in the sutures group at 1 and 6 months (P = 0.0132; P = 0.0052), as reflected by a lower proportion of patients using analgesics in the fibrin group over the study duration (65.2% vs 79.7%; P = 0.0009). Only 3 of 316 patients (0.9%) experienced recurrence. The incidences of wound-healing complications and other adverse events were comparable between groups.
Fibrin sealant for mesh fixation in Lichtenstein repair of small-medium sized inguinal hernias is well tolerated and reduces the rate of pain/numbness/groin discomfort by 45% relative to sutures without increasing hernia recurrence (NCT00306839).
验证纤维蛋白胶网片固定术可将术后疼痛/麻木/腹股沟不适发生率降低 50%的假设,与使用 Lichtenstein 技术修复腹股沟疝的缝线相比。
腹股沟疝修补术是普外科最常见的手术,因此,改进手术技术以降低不良术后结局的负担具有重要的临床意义。
在符合 Lichtenstein 修补术治疗单侧简单原发性小-中号腹股沟疝的患者中进行了一项随机、对照、患者和评估者设盲的研究(Tissucol/Tisseel for MEsh fixation in LIchtenstein hernia repair [TIMELI];试验 NCT00306839)。患者接受纤维蛋白胶或缝线网片固定。主要观察指标为视觉模拟量表(VAS)评估“疼痛”、“麻木”和“腹股沟不适”的评分,0 = 最佳,100 = 最差。主要终点是评估术后 12 个月慢性致残性并发症(疼痛/麻木/腹股沟不适 VAS 评分>30)发生率的复合指标。
2006 年 1 月至 2007 年 4 月间共 319 例患者随机分组,其中 159 例接受纤维蛋白胶,160 例接受缝线。12 个月时,纤维蛋白胶组的 1 种或多种致残性并发症的发生率显著低于缝线组(8.1%比 14.8%;P = 0.0344)。纤维蛋白胶组在 1 个月和 6 个月时报告的疼痛较轻(P = 0.0132;P = 0.0052),研究期间使用镇痛药的纤维蛋白组患者比例也较低(65.2%比 79.7%;P = 0.0009)。316 例患者中仅有 3 例(0.9%)复发。两组的伤口愈合并发症和其他不良事件发生率相当。
在 Lichtenstein 修补术中小-中号腹股沟疝中使用纤维蛋白胶网片固定术可耐受良好,与缝线相比,疼痛/麻木/腹股沟不适的发生率降低 45%,而疝复发率无增加(NCT00306839)。